Echinomycin
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Echinomycin
Description :
Echinomycin (Quinomycin A) is potent small-molecule and cell-permeable inhibitor of hypoxia-inducible factor-1 (HIF-1) DNA-binding activity. Echinomycin selectively inhibits the cancer stem cells (CSCs) with an IC50 of 29.4 pM[1][2].CAS Number :
[512-64-1]Product Name Alternative :
Quinomycin A; NSC-13502UNSPSC :
12352005Hazard Statement :
H301, H311, H331, H361Target :
Antibiotic; Bacterial; HIF/HIF Prolyl-HydroxylaseType :
Reference compoundRelated Pathways :
Anti-infection; Metabolic Enzyme/ProteaseApplications :
Cancer-programmed cell deathField of Research :
CancerAssay Protocol :
https://www.medchemexpress.com/echinomycin.htmlPurity :
98.57Solubility :
DMSO : 5.3 mg/mL (ultrasonic)Smiles :
[H]C1=NC2=C(N=C1C(N[C@H](COC([C@H](C(C)C)N(C)C([C@H]3N4C)=O)=O)C(N[C@@H](C)C(N(C)[C@@H]([C@@H](SC)SC3)C(N(C)[C@@H](C(C)C)C(OC[C@@H](NC(C5=NC6=C(C=CC=C6)N=C5[H])=O)C(N[C@@H](C)C4=O)=O)=O)=O)=O)=O)=O)C=CC=C2Molecular Formula :
C51H64N12O12S2Molecular Weight :
1101.26Precautions :
H301, H311, H331, H361References & Citations :
[1]Kong D, et al. Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity. Cancer Res. 2005 Oct 1;65 (19) :9047-55.|[2]Wang Y, et al. Targeting HIF1α eliminates cancer stem cells in hematological malignancies. Cell Stem Cell. 2011 Apr 8;8 (4) :399-411.Shipping Conditions :
Blue IceStorage Conditions :
-20°C (Powder, stored under nitrogen)Scientific Category :
Reference compound1Clinical Information :
No Development Reported

